Trials Sponsors Conditions Drugs Pricing

Conditions

Advanced Cancer Hypogonadism Pain

Keywords

Advanced CancerChronic Opioid TherapySecondary HypogonadismCancer-Related Pain SyndromesQuestionnaire

Outcome Measures

Primary Outcomes (1)

Prevalence of secondary hypogonadism in male patients on chronic opioid therapy for cancer-related pain syndromes
3 Years

Study Arms (1)

Chronic opioid therapy + Gonadal function

Males on chronic opioid therapy for cancer-related pain syndromes

Behavioral: QuestionnaireOther: Blood draws to assess gonadal function

Interventions

QuestionnaireBehavioral

A set of questionnaires regarding sexual function, physical and psychological symptoms.

Chronic opioid therapy + Gonadal function

Blood draws to assess gonadal functionOther

Testosterone, FSH, and LH levels at study onset.

Chronic opioid therapy + Gonadal function

Eligibility Criteria

Age18 Years+

Sexmale

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Males on chronic opioid therapy for cancer-related pain syndromes.

You may qualify if:

Chronic pain greater than one year.

Sponsors & Collaborators

M.D. Anderson Cancer Center
Otherlead

Study Sites (1)

U.T.M.D. Anderson Cancer Center

Houston, Texas, 77030, United States

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood draws to assess gonadal function.

MeSH Terms

Conditions

HypogonadismPain

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Gonadal DisordersEndocrine System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation Mechanisms

Study Officials

Arun Rajagopal, MD
M.D. Anderson Cancer Center
PRINCIPAL INVESTIGATOR

Enrollment

46 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

September 13, 2007

First Posted

September 14, 2007

Study Start

December 11, 2001

Actual (reported)

Study Stopped

Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Chronic opioid therapy + Gonadal function

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Chronic opioid therapy + Gonadal function

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations